TY - JOUR
T1 - Global developments in social prescribing
AU - Morse, Daniel
AU - Sandu, Sahil
AU - Mulligan, Kate
AU - Tierney, Stephanie
AU - Polley, Marie
AU - Giurca, Bogdan Chiva
AU - Slade, Sian
AU - Dias, Sonia
AU - Mahtani, Kamal R
AU - Wells, Leanne
AU - Wang, Huali
AU - Zhao, Bo
AU - de Figueiredo, Cristiano Emanuel Marta
AU - Meijs, Jan Joost
AU - Nam, Hae Kweun
AU - Lee, Kheng Hock
AU - Wallace, Carolyn
AU - Elliott, Megan
AU - Mendive, Juan Manuel
AU - Robinson, David
AU - Palo, Miia
AU - Herrmann, Wolfram
AU - Nielson, Rasmus Østergaard
AU - Husk, Keryn
N1 - © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
PY - 2022/5/16
Y1 - 2022/5/16
N2 - Social prescribing is an approach that aims to improve health and well-being. It connects individuals to non-clinical services and supports that address social needs, such as those related to loneliness, housing instability and mental health. At the person level, social prescribing can give individuals the knowledge, skills, motivation and confidence to manage their own health and well-being. At the society level, it can facilitate greater collaboration across health, social, and community sectors to promote integrated care and move beyond the traditional biomedical model of health. While the term social prescribing was first popularised in the UK, this practice has become more prevalent and widely publicised internationally over the last decade. This paper aims to illuminate the ways social prescribing has been conceptualised and implemented across 17 countries in Europe, Asia, Australia and North America. We draw from the ‘Beyond the Building Blocks’ framework to describe the essential inputs for adopting social prescribing into policy and practice, related to service delivery; social determinants and household production of health; workforce; leadership and governance; financing, community organisations and societal partnerships; health technology; and information, learning and accountability. Cross-cutting lessons can inform country and regional efforts to tailor social prescribing models to best support local needs.
AB - Social prescribing is an approach that aims to improve health and well-being. It connects individuals to non-clinical services and supports that address social needs, such as those related to loneliness, housing instability and mental health. At the person level, social prescribing can give individuals the knowledge, skills, motivation and confidence to manage their own health and well-being. At the society level, it can facilitate greater collaboration across health, social, and community sectors to promote integrated care and move beyond the traditional biomedical model of health. While the term social prescribing was first popularised in the UK, this practice has become more prevalent and widely publicised internationally over the last decade. This paper aims to illuminate the ways social prescribing has been conceptualised and implemented across 17 countries in Europe, Asia, Australia and North America. We draw from the ‘Beyond the Building Blocks’ framework to describe the essential inputs for adopting social prescribing into policy and practice, related to service delivery; social determinants and household production of health; workforce; leadership and governance; financing, community organisations and societal partnerships; health technology; and information, learning and accountability. Cross-cutting lessons can inform country and regional efforts to tailor social prescribing models to best support local needs.
KW - social prescribing
KW - global
U2 - 10.1136/bmjgh-2022-008524
DO - 10.1136/bmjgh-2022-008524
M3 - Article
C2 - 35577392
SN - 2059-7908
VL - 7
JO - BMJ Global Health
JF - BMJ Global Health
IS - 5
M1 - e008524
ER -